Baxter Pre-Tax Profit Margin 2010-2024 | BAX
Current and historical pre-tax profit margin for Baxter (BAX) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Baxter pre-tax profit margin for the three months ending December 31, 2024 was .
| Baxter Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-12-31 | $10.64B | $-0.29B | -2.72% |
| 2024-09-30 | $10.64B | $0.28B | 2.58% |
| 2024-06-30 | $10.54B | $0.27B | 2.56% |
| 2024-03-31 | $10.44B | $0.34B | 3.30% |
| 2023-12-31 | $10.36B | $0.24B | 2.34% |
| 2023-09-30 | $8.97B | $-0.62B | -6.93% |
| 2023-06-30 | $9.98B | $-3.73B | -37.39% |
| 2023-03-31 | $9.86B | $-3.33B | -33.74% |
| 2022-12-31 | $10.06B | $-3.25B | -32.30% |
| 2022-09-30 | $13.79B | $-2.81B | -20.38% |
| 2022-06-30 | $13.40B | $0.69B | 5.12% |
| 2022-03-31 | $12.91B | $0.86B | 6.66% |
| 2021-12-31 | $12.15B | $1.12B | 9.19% |
| 2021-09-30 | $12.45B | $1.40B | 11.28% |
| 2021-06-30 | $12.20B | $1.37B | 11.22% |
| 2021-03-31 | $11.82B | $1.27B | 10.70% |
| 2020-12-31 | $11.67B | $1.29B | 11.07% |
| 2020-09-30 | $11.53B | $0.86B | 7.45% |
| 2020-06-30 | $11.41B | $0.93B | 8.11% |
| 2020-03-31 | $11.53B | $0.96B | 8.35% |
| 2019-12-31 | $11.36B | $0.97B | 8.54% |
| 2019-09-30 | $11.14B | $1.60B | 14.32% |
| 2019-06-30 | $11.05B | $1.49B | 13.45% |
| 2019-03-31 | $11.06B | $1.57B | 14.15% |
| 2018-12-31 | $11.10B | $1.62B | 14.57% |
| 2018-09-30 | $11.08B | $1.39B | 12.55% |
| 2018-06-30 | $11.02B | $1.31B | 11.87% |
| 2018-03-31 | $10.79B | $1.21B | 11.22% |
| 2017-12-31 | $10.58B | $1.10B | 10.39% |
| 2017-09-30 | $10.43B | $1.20B | 11.53% |
| 2017-06-30 | $10.28B | $1.04B | 10.12% |
| 2017-03-31 | $10.26B | $1.95B | 19.03% |
| 2016-12-31 | $10.16B | $4.95B | 48.75% |
| 2016-09-30 | $10.12B | $4.88B | 48.22% |
| 2016-06-30 | $10.05B | $4.72B | 46.96% |
| 2016-03-31 | $9.94B | $3.61B | 36.31% |
| 2015-12-31 | $9.97B | $0.43B | 4.29% |
| 2015-09-30 | $10.15B | $0.33B | 3.27% |
| 2015-06-30 | $10.38B | $0.57B | 5.46% |
| 2015-03-31 | $12.06B | $1.06B | 8.80% |
| 2014-12-31 | $13.50B | $1.57B | 11.60% |
| 2014-09-30 | $15.03B | $1.98B | 13.18% |
| 2014-06-30 | $16.03B | $2.44B | 15.24% |
| 2014-03-31 | $15.55B | $2.58B | 16.62% |
| 2013-12-31 | $15.15B | $2.62B | 17.32% |
| 2013-09-30 | $14.33B | $2.62B | 18.31% |
| 2013-06-30 | $14.09B | $2.73B | 19.34% |
| 2013-03-31 | $14.00B | $2.80B | 20.00% |
| 2012-12-31 | $13.94B | $2.84B | 20.36% |
| 2012-09-30 | $14.03B | $2.86B | 20.40% |
| 2012-06-30 | $14.03B | $2.82B | 20.12% |
| 2012-03-31 | $14.00B | $2.81B | 20.08% |
| 2011-12-31 | $13.89B | $2.81B | 20.22% |
| 2011-09-30 | $13.80B | $2.73B | 19.77% |
| 2011-06-30 | $13.54B | $2.64B | 19.51% |
| 2011-03-31 | $13.20B | $2.51B | 19.01% |
| 2010-12-31 | $12.84B | $1.89B | 14.72% |
| 2010-09-30 | $12.82B | $2.14B | 16.68% |
| 2010-06-30 | $12.74B | $2.16B | 16.92% |
| 2010-03-31 | $12.67B | $2.21B | 17.44% |
| 2009-12-31 | $12.56B | $2.73B | 21.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.559B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $223.673B | 26.90 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.454B | 30.83 |
| EssilorLuxottica (ESLOY) | France | $127.910B | 0.00 |
| Medtronic (MDT) | Ireland | $108.054B | 15.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.940B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.883B | 26.67 |
| ResMed (RMD) | United States | $36.216B | 27.20 |
| GE HealthCare Technologies (GEHC) | United States | $33.352B | 15.84 |
| Agilent Technologies (A) | United States | $31.795B | 21.00 |
| Terumo (TRUMY) | Japan | $28.308B | 36.77 |
| Insulet (PODD) | United States | $22.619B | 88.79 |
| Koninklijke Philips (PHG) | Netherlands | $22.446B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.861B | 12.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.250B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.641B | 22.45 |
| Lantheus Holdings (LNTH) | United States | $5.453B | 13.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.220B | 18.85 |
| Perrigo (PRGO) | Ireland | $3.576B | 9.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.449B | 15.02 |
| ICU Medical (ICUI) | United States | $3.346B | 24.67 |
| Envista Holdings (NVST) | United States | $3.039B | 25.25 |
| QuidelOrtho (QDEL) | United States | $2.269B | 15.60 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.92 |
| AtriCure (ATRC) | United States | $1.597B | 0.00 |
| Neogen (NEOG) | United States | $1.385B | 17.72 |
| AdaptHealth (AHCO) | United States | $1.200B | 12.19 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.150B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.047B | 0.00 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.946B | 12.10 |
| Evolus (EOLS) | United States | $0.644B | 0.00 |
| CeriBell (CBLL) | United States | $0.595B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.585B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.49 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.444B | 0.00 |
| Surmodics (SRDX) | United States | $0.399B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.350B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.341B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.307B | 11.29 |
| Sanuwave Health (SNWV) | United States | $0.293B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.283B | 50.40 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Verano Holdings (VRNOF) | United States | $0.261B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.06 |
| Brainsway (BWAY) | Israel | $0.194B | 51.35 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.38 |
| Quanterix (QTRX) | United States | $0.166B | 0.00 |
| Organigram Global (OGI) | Canada | $0.163B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.18 |
| Exagen (XGN) | United States | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.64 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |